Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.14
+0.16 (3.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for FHTX stock have an average target of 13.8, with a low estimate of 9.00 and a high estimate of 20. The average target predicts an increase of 168.48% from the current stock price of 5.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FHTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 → $13 | Strong Buy | Reiterates | $20 → $13 | +152.92% | Dec 17, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +172.37% | Dec 16, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $6 → $9 | Hold | Maintains | $6 → $9 | +75.10% | Sep 24, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +250.19% | Sep 3, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $20 | Buy | Initiates | $20 | +289.11% | Aug 19, 2024 |
Financial Forecast
Revenue This Year
31.69M
from 34.16M
Decreased by -7.21%
Revenue Next Year
35.35M
from 31.69M
Increased by 11.54%
EPS This Year
-1.68
from -2.34
EPS Next Year
-1.42
from -1.68
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 47.3M | 52.5M | 63.0M | |||
| Avg | 31.7M | 35.4M | 42.1M | |||
| Low | 27.1M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 38.3% | 65.6% | 78.2% | |||
| Avg | -7.2% | 11.5% | 19.1% | |||
| Low | -20.5% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.50 | -0.58 | -1.08 | |||
| Avg | -1.68 | -1.42 | -1.52 | |||
| Low | -1.92 | -2.26 | -2.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.